CY777A - Anti-viral and immune suppressant compositions - Google Patents

Anti-viral and immune suppressant compositions

Info

Publication number
CY777A
CY777A CY77770A CY77770A CY777A CY 777 A CY777 A CY 777A CY 77770 A CY77770 A CY 77770A CY 77770 A CY77770 A CY 77770A CY 777 A CY777 A CY 777A
Authority
CY
Cyprus
Prior art keywords
viral
immune suppressant
suppressant compositions
compositions
immune
Prior art date
Application number
CY77770A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CY777A publication Critical patent/CY777A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/84—Naphthothiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY77770A 1969-01-28 1970-01-28 Anti-viral and immune suppressant compositions CY777A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79474969A 1969-01-28 1969-01-28
US79475669A 1969-01-28 1969-01-28

Publications (1)

Publication Number Publication Date
CY777A true CY777A (en) 1975-03-01

Family

ID=27121543

Family Applications (1)

Application Number Title Priority Date Filing Date
CY77770A CY777A (en) 1969-01-28 1970-01-28 Anti-viral and immune suppressant compositions

Country Status (6)

Country Link
BE (1) BE744970A (xx)
CY (1) CY777A (xx)
DE (1) DE2003841C3 (xx)
FR (1) FR2034500B1 (xx)
GB (1) GB1296561A (xx)
MY (1) MY7500001A (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
BE792606A (fr) * 1972-01-06 1973-03-30 Ferlux Nouveaux semicarbazides et thiosemicarbazides et leur preparation
FR2186238A1 (en) * 1972-05-05 1974-01-11 Ferlux N-2-imidazolinyl-N'-acylhydrazides - with analgesic hypotensive and cardiac stimulant activity
US3932434A (en) * 1974-08-30 1976-01-13 Eli Lilly And Company N-2-(6-hydroxybenzothiazolyl)-N'-phenyl (or substituted phenyl) ureas
US4046770A (en) 1974-08-30 1977-09-06 Eli Lilly And Company N-(6-acyloxybenzothiazol-2-yl)-N'-phenyl (or substituted phenyl)ureas
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6362208B1 (en) 1997-03-25 2002-03-26 Kowa Company, Ltd. Anilide compounds and drugs containing the same
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6380232B1 (en) * 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
MX2007001271A (es) * 2004-08-05 2007-03-21 Hoffmann La Roche N-acil-2-aminotiazoles sustituidos.
CA2892899C (en) 2012-12-21 2021-07-20 Janssen Sciences Ireland Uc Antibacterial compounds
US9073946B2 (en) * 2013-01-15 2015-07-07 Kineta, Inc. Anti-viral compounds

Also Published As

Publication number Publication date
DE2003841B2 (de) 1973-09-06
FR2034500A1 (xx) 1970-12-11
GB1296561A (xx) 1972-11-15
MY7500001A (en) 1975-12-31
FR2034500B1 (xx) 1974-06-14
DE2003841A1 (de) 1970-07-30
BE744970A (fr) 1970-07-27
DE2003841C3 (de) 1974-04-11

Similar Documents

Publication Publication Date Title
IL35714A (en) Water soluble aspirin compositions and their preparation
IL34383A0 (en) 2-acylimidazoles and their preparation
IL34415A0 (en) Imido-substituted organopolysiloxane compositions
ZA703937B (en) Anti-viral processes and compositions
IL35047A0 (en) New beta-aryl-2-aminoalkoxy-styrenes and their preparation
MY7500001A (en) Anti-viral and immune suppressant compositions
IL34434A0 (en) 6-substituted tetrahydropyran-2-ols and their preparation
IL34980A0 (en) Pleuromutilin derivatives and their preparation
IL35571A (en) N-phenylbicycloheptyl carbamates and preparation thereof
ZM13670A1 (en) Pesticidal compounds and compositions
IL34725A0 (en) Micronutrients and their preparation
PH10499A (en) 2-amidopenicillins and pharmaceutical compositions containing them
CY845A (en) Antiineectious pharmaceutical compositions
ZA70282B (en) Anti-viral agents and immune suppressants
IL33812A0 (en) 9alpha-fluoro-16-fluoromethylene-prednisolone-21-ester and preparation thereof
IL31519A (en) Polymeric compositions and their preparation
CY779A (en) 1-substituted-6-7-methylenedioxy-4(1h)-oxocinnoline-3-carbonitriles and their preparation
ZA704998B (en) Pharmaceutical compositions
IL33030A0 (en) 1-carbamoylpyrazole-4-sulfonamides and pharmaceutical compositions containing them
AU445661B2 (en) Antiviral agents and immune suppressants
AU1042470A (en) Antiviral agents and immune suppressants
IL34965A0 (en) 3-amino-4-hydrocarbylthioazetidin-2-one derivatives and their preparation
IL34084A (en) N-phosphoryl-,n-phosphonyl-,n-thionophosphoryl-and n-thionophosphonyl-3-methyl-5-hydroxypyrazole derivatives and their preparation
ZA695903B (en) Pharmaceutical compositions
IE33136B1 (en) Coating compositions and preparation thereof